1. A Multipurpose First‐in‐Human Study With the Novel CXCR7 Antagonist ACT‐1004‐1239 Using CXCL12 Plasma Concentrations as Target Engagement Biomarker. Issue 6 (15th February 2021) Authors: Huynh, Christine; Henrich, Andrea; Strasser, Daniel S.; Boof, Marie‐Laure; Al‐Ibrahim, Mohamed; Meyer Zu Schwabedissen, Henriette E.; Dingemanse, Jasper; Ufer, Mike Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 6(2021) Page Start: 1648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease. (8th January 2021) Authors: Boof, Marie‐Laure; Dingemanse, Jasper; Brunke, Mareile; Esselmann, Albert; Heymer, Peter; Kestermann, Olaf; Lederer, Katharina; Fietze, Ingo; Ufer, Mike Journal: Journal of sleep research Issue: Volume 30:Number 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗